CEVA INC (CEVA)

US1572101053 - Common Stock

20.4  +0.42 (+2.1%)

Fundamental Rating

4

Taking everything into account, CEVA scores 4 out of 10 in our fundamental rating. CEVA was compared to 107 industry peers in the Semiconductors & Semiconductor Equipment industry. CEVA has a great financial health rating, but its profitability evaluates not so good. While showing a medium growth rate, CEVA is valued expensive at the moment.



2

1. Profitability

1.1 Basic Checks

In the past year CEVA was profitable.
In the past year CEVA has reported a negative cash flow from operations.
In the past 5 years CEVA reported 4 times negative net income.
CEVA had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

CEVA's Return On Assets of -3.91% is on the low side compared to the rest of the industry. CEVA is outperformed by 62.26% of its industry peers.
CEVA has a Return On Equity (-4.49%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -3.91%
ROE -4.49%
ROIC N/A
ROA(3y)-3.77%
ROA(5y)-2.42%
ROE(3y)-4.44%
ROE(5y)-2.85%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CEVA has a better Gross Margin (88.04%) than 98.11% of its industry peers.
CEVA's Gross Margin has been stable in the last couple of years.
CEVA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 88.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.48%
GM growth 5Y-0.38%

8

2. Health

2.1 Basic Checks

CEVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CEVA has more shares outstanding
Compared to 5 years ago, CEVA has more shares outstanding
CEVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

CEVA has an Altman-Z score of 8.10. This indicates that CEVA is financially healthy and has little risk of bankruptcy at the moment.
CEVA has a Altman-Z score of 8.10. This is in the better half of the industry: CEVA outperforms 75.47% of its industry peers.
There is no outstanding debt for CEVA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 8.1
ROIC/WACCN/A
WACC11.81%

2.3 Liquidity

A Current Ratio of 7.79 indicates that CEVA has no problem at all paying its short term obligations.
With an excellent Current ratio value of 7.79, CEVA belongs to the best of the industry, outperforming 92.45% of the companies in the same industry.
CEVA has a Quick Ratio of 7.79. This indicates that CEVA is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 7.79, CEVA belongs to the best of the industry, outperforming 96.23% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.79
Quick Ratio 7.79

4

3. Growth

3.1 Past

CEVA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -87.34%.
Measured over the past years, CEVA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -28.63% on average per year.
The Revenue for CEVA has decreased by -21.20% in the past year. This is quite bad
CEVA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.57% yearly.
EPS 1Y (TTM)-87.34%
EPS 3Y-44.66%
EPS 5Y-28.63%
EPS growth Q2Q-56.52%
Revenue 1Y (TTM)-21.2%
Revenue growth 3Y-0.97%
Revenue growth 5Y4.57%
Revenue growth Q2Q-27.66%

3.2 Future

The Earnings Per Share is expected to grow by 79.81% on average over the next years. This is a very strong growth
CEVA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.67% yearly.
EPS Next Y214.84%
EPS Next 2Y125.29%
EPS Next 3Y79.81%
EPS Next 5YN/A
Revenue Next Year-2.83%
Revenue Next 2Y3.7%
Revenue Next 3Y5.67%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 204.00, the valuation of CEVA can be described as expensive.
Based on the Price/Earnings ratio, CEVA is valued a bit more expensive than the industry average as 64.15% of the companies are valued more cheaply.
The average S&P500 Price/Earnings ratio is at 24.84. CEVA is valued rather expensively when compared to this.
CEVA is valuated quite expensively with a Price/Forward Earnings ratio of 64.79.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CEVA indicates a slightly more expensive valuation: CEVA is more expensive than 60.38% of the companies listed in the same industry.
CEVA is valuated expensively when we compare the Price/Forward Earnings ratio to 21.35, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 204
Fwd PE 64.79

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

CEVA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CEVA's earnings are expected to grow with 79.81% in the coming years.
PEG (NY)0.95
PEG (5Y)N/A
EPS Next 2Y125.29%
EPS Next 3Y79.81%

0

5. Dividend

5.1 Amount

No dividends for CEVA!.
Industry RankSector Rank
Dividend Yield N/A

CEVA INC

NASDAQ:CEVA (4/29/2024, 12:18:01 PM)

20.4

+0.42 (+2.1%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap481.03M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 204
Fwd PE 64.79
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.95
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.91%
ROE -4.49%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 88.04%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 7.79
Quick Ratio 7.79
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-87.34%
EPS 3Y-44.66%
EPS 5Y
EPS growth Q2Q
EPS Next Y214.84%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-21.2%
Revenue growth 3Y-0.97%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y